Boston Scientific (BSX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 5 |
| Ownership rank: | 157 |
| % of all portfolios: | 0.043% |
| Hold Price * : | $62.75 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
3 |
$16,801,583 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Lee Ainslie - Maverick Capital |
3.06 |
Add 42.48% |
4,195,089 |
263,242,000 |
| ≡ |
Polen Capital Management |
0.25 |
Reduce 85.58% |
579,739 |
36,379,000 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
0.05 |
Reduce 48.11% |
104,655 |
6,567,000 |
| ≡ |
Mairs & Power Funds |
0.01 |
|
10,176 |
639,000 |
| ≡ |
Dodge & Cox Funds |
0.00 |
|
88,885 |
5,578,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 13 Feb 2025 |
FITZGERALD JOSEPH MICHAEL |
EVP & Group Pres, Cardiology |
03 Dec 2024 |
50 |
90.29 |
4,515 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock